These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31823959)

  • 41. Erratum: Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Sci Data; 2018 Mar; 5():180041. PubMed ID: 29557974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B-vitamins intake, DNA-methylation of One Carbon Metabolism and homocysteine pathway genes and myocardial infarction risk: the EPICOR study.
    Fiorito G; Guarrera S; Valle C; Ricceri F; Russo A; Grioni S; Mattiello A; Di Gaetano C; Rosa F; Modica F; Iacoviello L; Frasca G; Tumino R; Krogh V; Panico S; Vineis P; Sacerdote C; Matullo G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):483-8. PubMed ID: 24418380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck.
    Mandapathil M
    HNO; 2016 May; 64(5):303-9. PubMed ID: 27052632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Int J Cancer; 2005 Sep; 116(3):422-7. PubMed ID: 15818624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erratum: Health-related quality of life of patients with squamous cell carcinoma: a comparison according to tumor location. Braz Oral Res. 2017;31:e105.
    Braz Oral Res; 2018 Feb; 32():e105err. PubMed ID: 29412220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma.
    Boven L; Holmes SP; Latimer B; McMartin K; Ma X; Moore-Medlin T; Khandelwal AR; McLarty J; Nathan CO
    Laryngoscope; 2019 Jul; 129(7):1597-1603. PubMed ID: 30421467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis.
    Young ER; Diakos E; Khalid-Raja M; Mehanna H
    Clin Otolaryngol; 2015 Jun; 40(3):208-18. PubMed ID: 25358605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
    Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
    Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
    Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
    Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.
    Foulkes WD; Brunet JS; Sieh W; Black MJ; Shenouda G; Narod SA
    BMJ; 1996 Sep; 313(7059):716-21. PubMed ID: 8819440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
    Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
    Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes.
    Abdel Razek AAK
    Magn Reson Imaging; 2018 Dec; 54():84-89. PubMed ID: 30142392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.
    Loo SW; Geropantas K; Tasigiannopoulos Z; Martin C; Roques TW
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):32-40. PubMed ID: 22519981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of Tiam 1 on cell proliferation and migration in head and neck squamous cell carcinoma cells].
    Xiao P; Fu Q; Li Z; Zhang X; Fu X; Wan R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):633-7. PubMed ID: 26201191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck.
    Li JZ; Zheng JW; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2008 Feb; 17(1):1-5. PubMed ID: 18360658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum.
    Arq Bras Cir Dig; 2017; 30(2):164. PubMed ID: 29257858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.